Functional and pharmacological properties of canine ERG potassium channels

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  Wang, Jixin ^a   Della Penna, Kimberly ^a   Wang, Hao ^a   Karczewski, Jerzy ^a   Connolly, Thomas M ^a   Koblan, Kenneth S ^a   Bennett, Paul B ^a   Salata, Joseph J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Acquired long QT syndrome, potassium ion channel; Canine ether go go related gene; Ion channels; Ventricular arrhythmia

Indexed keywords

1' (6 CYANO 1,2,3,4 TETRAHYDRO 2 NAPHTHYL) 3,4 DIHYDRO 6 METHANESULFONAMIDOSPIRO[2H 1 BENZOPYRAN 2,4' PIPERIDIN] 4 OL; ASTEMIZOLE; CISAPRIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; ION CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; SULFUR 35; TERFENADINE;

ANIMAL MODEL; ARTICLE; CELL CULTURE; DOG; EMBRYO; ETHER A GO GO RELATED GENE; GENE; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; ISOTOPE LABELING; LONG QT SYNDROME; MEMBRANE POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; VOLTAGE CLAMP;

EID: 0037235024     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00220.2002     Document Type: Article

References (38)

1. Bennett PB and Johnson JP. Molecular physiology of cardiac ion channels. In: Basic Cardiac Electrophysiology and Pharmacology (1st Ed.), edited by Zaza A and Rosen M. Newark, NJ: Harwood Academic, 2000, p. 29-57.
2. Clay JR, Ogbaghebriel A, Paquette T, Sasyniuk BI, and Shrier A. A quantitative description of the E-4031-sensitive repolarization current in rabbit ventricular myocytes. Biophys J 69: 1830-1837, 1995.
3. Crumb WJ Jr, Wible B, Arnold DJ, Payne JP, and Brown AM. Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: Possible mechanism for terfenadine-associated cardiotoxicity. Mol Pharmacol 47: 181-190, 1995.
4. Drolet B, Khalifa M, Daleau P, Hamelin BA, and Turgeon J. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation 97: 204-210, 1998.
5. Johnson JP Jr, Balser JR, and Bennett PB. A novel extra-cellular calcium sensing mechanism in voltage-gated potassium ion channels. J Neurosci 21: 4143-4153, 2001.
6. 2+ - Evidence for two distinct voltage sensors. J Gen Physiol 113:565-580,1999.
7. Kiehn J, Lacerda A, Wible B, and Brown AM. Molecular physiology and pharmacology of HERG: Single channel currents and block by dofetilide. Circulation 94: 2572-2579, 1996.
8. Limbird L. Cell Surface Receptors: A Short Course on Theory and Methods. Boston: Nijhof, 1986.
9. Ks contributes to the longer action potential of the M cell. Circ Res 76: 351-365,1995.
10. Liu S, Rasmusson RL, Campbell DL, Wang S, and Strauss HC. Activation and inactivation kinetics of an E-4031-sensitive current from single ferret atrial myocytes. Biophys J 70:2704-2715,1996.
11. Lynch JJ, Wallace AA, Stupienski RF, Baskin EP, Beare CM, Appleby SD, Salata JJ, Jurkiewicz NK, Sanguinetti MC, Stein RB, Gehret JR, Kothstein T, Claremon DA, Elliott JM, Butcher JW, Remy DC, and Baldwin JJ. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]. J Pharmacol Exp Ther 269: 541-54, 1994.
12. Mitcheson JS, Chen J, Lin M, Culberson C, and Sanguinetti MC. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 97: 12329-12333, 2000.
13. Mitcheson JS, Chen J, and Sanguinetti MC. Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate. J Gen Physiol 115: 229-240, 2000.
14. + channel by the gastrointestinal prokinetic agent cisapride. Am J Physiol Heart Circ Physiol 273: H2534-H2538, 1997.
15. + channel diversity in the mammalian myocardium. J Physiol 525: 285-298, 2000.
16. Noble D and Tsien RW. Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres. J Physiol 200: 205-231, 1969.
17. + channels in microglia. J Gen Physiol 111: 795-805, 1998.
18. Rampe D, Roy ML, Dennis A, and Brown AM. A mechanism for the proarrhythmic effects of cisapride (Propulsid): High affinity blockade of the human cardiac potassium channel HERG. FEBS Lett 417: 28-32, 1997.
19. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, and Vincent GM. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. Circulation 94: 1996-2012, 1996.
20. Roy M, Dumaine R, and Brown AM. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 94: 817-823, 1996.
21. 1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 76: 110-119, 1995.
22. Kr potassium channel. Cell 81: 299-307, 1995.
23. + current: Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96: 195-215, 1990.
24. Smith PL, Baukrowitz T, and Yellen G. The inward rectification mechanism of the HERG cardiac potassium channel. Nature 379: 833-836, 1996.
25. Snyders DJ and Chaudhary A. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol 49: 949-955, 1996.
26. + channel. Open-channel block by methane-sulfonanilides. Circ Res 78: 499-503, 1996.
27. Kr channel. J Gen Physiol 107: 611-619, 1996.
28. Suessbrich H, Waldegger S, Lang F, and Busch AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett 385: 77-80, 1996.
29. Trudeau M, Warmke JW, Ganetzky B, and Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 269: 92-95, 1995.
30. Veldkamp MW, van Ginneken ACG, Opthof T, and Bouman LN. Delayed rectifier channels in human ventricular myocytes. Circulation 92: 3497-3504, 1995.
31. Walker BD, Singleton CB, Bursill JA, Wyse KR, Valenzuela SM, Qiu MR, Breit SN, and Campbell TJ. Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: Affinity for open and inactivated states. Br J Pharmacol 128: 444-450, 1999.
32. + channels in terminal and juxtaparanodal regions of neurons, Nature 365: 75-79, 1993.
33. Wang S, Liu S, Morales MJ, Strauss HC, and Rasmusson RL. A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes. J Physiol 502: 45-60, 1997.
34. Wang Z, Fermini B, and Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res 28: 1540-1546, 1994.
35. Warmke JW and Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA 91: 3438-3442, 1994.
36. Zehelein Z, Zhang W, Koenen M, Graf M, Heinemann SH, and Katus HA. Molecular cloning and expression of cERG, the ether a go-go-related gene from canine myocardium. Pflügers Arch 442: 188-191, 2001.
37. Zhou ZF, Gong QM, Ye B, Fan Z, Makielski JC, Robertson GA, and January CT. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 74: 230-241, 1998.
38. Zhou ZF, Vorperian VR, Gong QM, Zhang ST, and January CT. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole. J Cardiovasc Electrophysiol 10: 836-843, 1999.